6 BioSpectrum | February 2012 | www.BioSpectrumIndia.com | A CyberMedia Publication

► HR Analysis - What does it take to retain R&D talent?

► Vaccine research laps up Indo-US deals

► Opportunities amidst crisis

► Polio in exit mode: Is the battle over yet?

BioContent

BioSpecial

Scientists making a difference► Making NCE a reality in India Dr Sivaramakrishnan, president, R&D, Piramal Life Sciences, Mumbai

► Tailoring reagents to R&D needs Dr Manjula Das, CSO, Abexome Biosciences, Bangalore

► In search of dengue vaccine Dr Navin Khanna, group leader, Mammalian Biology Division, ICGEB, New Delhi

Taking diseases head-on

48

BioSpecial

30

33

BioContent

17

CSO Series

56

64

74

CoverStory

MISSION Boosting efforts to combat hepatitis C An indigenous rotavirus vaccine Rapid diagnostic detection of dengue

Affordable cancer treatment Competition hots up

40Big and small biopharma companies are trying to capitalize on the India oncology market via diagnostics, drug development and biosimilars. A report

HOT SEGMENT BIOLOGICSBiotech companies are ramping up their facilities and quality standards to meet the patent expiry challenge.

Government regulations also need to match up.

A Special Report

A CyberMedia Publication | www.BioSpectrumIndia.com | February 2012 | BioSpectrum 7

BioAnalysis ...................................................... 12► Pentavalent vaccines: A new era in immunization

BioTalk

► Mr Peter Bains, non-executive chairman, .................. 62 Fermenta Biotech

► Dr Rajesh Jain, JMD, Panacea Biotec .......................... 70► Mr Jignesh Bhate, CEO, Molecular Connections ........ 78BioSupplier ...................................................... 82► Mr Deepak Parab, CEO, Metrohm India

► Mr Adie Cleaver, managing director, Cleaver Scientific

BioNews ................................................................... 88► Cryo-Save India gets AABB accreditation

► Barcoding to reduce counterfeit drugs

BioServices ......................................................... 90► ISO certification for Semler Research Center

BioPolicy ................................................................... 91► Strides subsidiaries get FDA approvals

BioResearch ...................................................... 92► Artemisia annua trials get nod

BioPeople ................................................................ 93► Padma Shri for four industry stalwarts

BioEvents ............................................................... 95BioBuzz ...................................................................... 96► From umbilical cells to brain cells

BioComment .................................................100► Expand the biotech market

BioEdit ......................................................................... 09► India’s biotech innovators need some help